Current:Home > StocksFDA pulls the only approved drug for preventing premature birth off the market-DB Wealth Institute B2 Expert Reviews
FDA pulls the only approved drug for preventing premature birth off the market
View Date:2024-12-23 19:56:35
The Food and Drug Administration is pulling its approval for a controversial drug that was intended to prevent premature births, but that studies showed wasn't effective.
Following years of back-and-forth between the agency and the drugmaker Covis Pharma, the FDA's decision came suddenly Thursday. It means the medication, Makena, and its generics are no longer approved drug products and can no longer "lawfully be distributed in interstate commerce," according to an agency statement.
"It is tragic that the scientific research and medical communities have not yet found a treatment shown to be effective in preventing preterm birth and improving neonatal outcomes," FDA Commissioner Robert M. Califf said in a statement on Thursday.
Hundreds of thousands of babies are born preterm every year in the U.S. It's one of the leading causes of infant deaths, according to a report released by the March of Dimes last year. And preterm birth rates are highest for Black infants compared to other racial and ethnic groups. There is no other approved treatment for preventing preterm birth.
Last month, Covis said it would pull Makena voluntarily, but it wanted that process to wind down over several months. On Thursday, the FDA rejected that proposal.
Makena was granted what's known as accelerated approval in 2011. Under accelerated approval, drugs can get on the market faster because their approvals are based on early data. But there's a catch: drugmakers need to do follow-up studies to confirm those drugs really work.
The results of studies later done on Makena were disappointing, so in 2020 the FDA recommended withdrawing the drug. But because Covis didn't voluntarily remove the drug at the time, a hearing was held in October – two years later – to discuss its potential withdrawal.
Ultimately, a panel of outside experts voted 14-1 to take the drug off the market.
But the FDA commissioner still needed to make a final decision.
In their decision to pull the drug immediately, Califf and chief scientist Namandjé Bumpus quoted one of the agency's advisors, Dr. Anjali Kaimal, an obstetrics and gynecology professor at the University of South Florida.
Kaimal said there should be another trial to test the drug's efficacy, but in the meantime, it doesn't make sense to give patients a medicine that doesn't appear to work: "Faced with that powerless feeling, is false hope really any hope at all?"
veryGood! (3)
Related
- Pistons' Tim Hardaway Jr. leaves in wheelchair after banging head on court
- 'I cried like a baby': Georgia town mourns after 4 killed in school shooting
- The New Jersey developer convicted with Bob Menendez pleads guilty to bank fraud
- 'Bachelorette' Jenn Tran addresses finale debacle: 'My heart is heavy grieving'
- Former North Carolina labor commissioner becomes hospital group’s CEO
- Marlon Wayans almost cut out crying on Netflix special over death of parents
- Target adds 1,300 new Halloween products for 2024, including $15 costumes
- Sister Wives' Janelle Brown Shares Heartbreaking Message to Son Garrison 6 Months After His Death
- ‘Heretic’ and Hugh Grant debut with $11 million, but ‘Venom: The Last Dance’ tops box office again
- The Toronto International Film Festival is kicking off. Here are 5 things to look for this year
Ranking
- Two 'incredibly rare' sea serpents seen in Southern California waters months apart
- Usher premieres Paris concert film at the Apollo with roses, 'Ushbucks' and sensuality
- Christina Hall Stresses Importance of Making Her Own Money Amid Josh Hall Divorce
- Ben Affleck's Past Quotes on Failed Relationships Resurface Amid Jennifer Lopez Divorce
- 'Unfortunate error': 'Wicked' dolls with porn site on packaging pulled from Target, Amazon
- Defensive coordinator Richard Aspinwall among 4 killed in Georgia high school shooting
- FBI received tips about online threats involving suspected Georgia shooter | The Excerpt
- California schools release a blizzard of data, and that’s why parents can’t make sense of it
Recommendation
-
Here's Your First Look at The White Lotus Season 3 With Blackpink’s Lisa and More Stars
-
Police deny Venezuela gang has taken over rundown apartment complex in Denver suburb
-
Atlantic City’s top casino underpaid its online gambling taxes by $1.1M, regulators say
-
Missouri judge says abortion-rights measure summary penned by GOP official is misleading
-
Sister Wives’ Meri Brown Shares Hysterical Farmers Only Dating Profile Video After Kody Split
-
George Kittle, Trent Williams explain how 49ers are galvanized by Ricky Pearsall shooting
-
Harvey Weinstein UK indecent assault case dropped over chance of conviction
-
Peacock's star-studded 'Fight Night' is the heist you won't believe is real: Review